FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

37686311000001109: Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2885421000001113 Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2885441000001115 Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) Is a Xylometazoline 70micrograms/dose / Ipratropium bromide 84micrograms/dose nasal spray true Inferred relationship Existential restriction modifier
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) Is a Otrivine true Inferred relationship Existential restriction modifier
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) Has specific active ingredient Xylometazoline hydrochloride true Inferred relationship Existential restriction modifier
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) Has specific active ingredient Ipratropium bromide true Inferred relationship Existential restriction modifier
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) 70 dose Has AMP True Otrivine Extra Dual Relief 0.5mg/ml / 0.6mg/ml nasal spray (Haleon UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start